プロテオミクスの世界市場

【英語タイトル】Global Proteomics Industry

Global Industry Analystsが出版した調査資料(GIA906037)・商品コード:GIA906037
・発行会社(調査会社):Global Industry Analysts
・発行日:2019年5月
・ページ数:261
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD5,600 ⇒換算¥599,200見積依頼/購入/質問フォーム
Five UserUSD7,840 ⇒換算¥838,880見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Global Industry Analystsが発行した当調査レポートでは、プロテオミクスの世界市場について調査・分析し、プロテオミクスの世界市場規模、世界市場動向、世界市場予測、セグメント別分析、主要地域分析・市場規模予測、関連企業情報などをお届けいたします。
【レポートの概要】

This report analyzes the worldwide markets for Proteomics in US$ Million.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 75 companies including many key and niche players such as:
- ActivX Biosciences, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Daltonics, Inc.
- Caprion Biosciences, Inc.
- Digilab, Inc.

【レポートの目次】

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW

Proteomics – The Current Spotlight
Proteomics Market to Grow at a Phenomenal Rate
Proteomics: A Critical Drug Discovery Tool
Research to Dominate the Market in the Immediate Future
The Stoller Biomarker Discovery Centre – Establishing the Most Comprehensive Proteomics Solutions
Proteomics Technologies: Growing in Significance
Proteomics Technological Developments and Innovations
New Technological Advancements
Innovations in Proteomics

2. MARKET DRIVERS/TRENDS/CHALLENGES

Personalized Medicine Market Driven by Constraints in Traditional Treatment Approach
Table 1: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population (includes corresponding Graph/Chart)
Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
Table 2: Leading Personalized Medicines Worldwide (2015-2017): Annual Sales of Select Leading Medicines in US$ Million (includes corresponding Graph/Chart)
Rising Investment in Proteomics R&D
Ballooning Global Population Offers Significant Growth Opportunities
Table 3: World Population (In Million) for the Years 2018-2050 (includes corresponding Graph/Chart)
Table 4: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (includes corresponding Graph/Chart)
Aging Global Population Drives Proteomics
Table 5: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Table 6: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
Table 7: Global Population Statistics for the 60+ Age Group by Region (2017) (includes corresponding Graph/Chart)
Advancements in Proteomics Bring Biomarkers into Limelight
List of US-FDA Approved Biomarkers for Cancer
Oncology – A Key Focus Area for Proteomics
Table 8: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)
Table 9: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)
International Initiatives in the Proteomics Market
China All Set To Play a Major Role in the Proteomics Industry
Global Proteomics Sample Preparation Market – On a Growth Curve
Challenges Facing Proteomics Sample Preparation Market
Industrialization of Proteomics Research Propels Sample Preparation Technologies
Factors Limiting Market Growth
Market Restrains/Challenges
Expensive Equipment
Lack of Proficient Researchers
Protein Chemistry and its Complexities
Quantitation
Integration of Data & Equipment
Data Validation – A Burning Issue
Standardization & Consistency – A Prime Concern
Incomplete and Disorganized Data

3. INDUSTRY COMPETITION

A Highly Fragmented Market
Proteomics Product and Service Suppliers
Tool Providers: Leading the Proteomics Market
Role of Contract Research Organizations – All Set to Increase in Proteomics

4. PRODUCT AND TECHNOLOGY OVERVIEW

Proteins, Proteome and Proteomics!!! – What are They?
Proteomics – An Introduction
Genesis of Proteomics
Tales from Times Gone By
Components of Proteomics
Expression Proteomics
Functional Proteomics
Cell-map Proteomics
Structural Proteomics
Technologies and Proteomics
Proteomics and Genomics
Proteomics and Genomics: A Comparison
Protein Production Pathway: From Gene Expression to Functional Protein with Controls
From Genomics to Proteomics
Functional Genomics and Proteomics
Push from Genomic Information
An Insight into Proteomics Data Type and their Characteristics / Features
Standard Proteomics Approach
Sample Preparation – Step I
Protein Separation – Step II
Protein Visualization
Protein Expression Analysis-Step III
Image Analysis – Identify differentially expressed spots
Protein Identification – Step IV
Data Storage and Processing – Step V

5. OVERVIEW OF PROTEOMICS TECHNOLOGIES

A Snapshot of Various Proteomics Tools
An Insight into Various Proteomics Technologies and their Application Areas
Protein Separation
2-Dimensional Gel Electrophoresis (2DGE)
Elements of 2-DE Proteomics
Two – Dimensional Differential Gel Electrophoresis
Combining 2D Gel Electrophoresis with Mass Spectrometry (MS)
2D Capillary LC
Analytical Strength of LC-MS and MS/MS in Shotgun Protein Sequencing
Protein Characterization
Analysis of Protein through Mass Spectrometry
MS and Proteins
Comparison of MS Techniques
Applications of MS
Problems Associated with MS
Types of Analyzers or Filters
MALDI-TOF MS
MS/MS
SELDI-TOF
Laser Capture Microdissection
Tandem MS
Y2H, Yeast 2-Hybrid System
Sensitivity of Two-Hybrid Assays
Limitations of Y2H
Protein Microarrays
Market Influencers in Protein Microarrays Market
Chip Technology
Microfluidic Applications
Role of Bioinformatics in Proteomics
Bioinformatics Applications and Tools in Proteomics
MS Programs
2- DE gel Comparison
2-DE Databases
Databases of 2D-electrophoretic maps
Emerging Proteomics Technologies
MudPIT
ICAT
ICAT strategy: A solution to quantitative proteome analysis
Phage Display Technique
Advanced Proteomics Technologies: Structural Analysis Tools
X-ray Crystallography
Nuclear Magnetic Resonance (NMR)
In silico Modelling
Physicochemical Factors Constraining Metabolic Functions

6. END-USE APPLICATION AREAS

Proteomics in Drug Discovery and Diagnostics
Proteomics and Drug Discovery
Protein Microarrays: A New Tool for the Development of Pharmaceuticals
Proteomic Approaches Gain Prominence in Cancer Drug Discovery
Proteomics Technologies Used in Cancer Drug Discovery and Development

7. NEW PRODUCT LAUNCHES/ DEVELOPMENTS

PharmaFluidics Introduces µPAC
Bruker Introduces the timsTOF Pro System for PASEF Mass Spectrometry
NanoString Introduces Genomics and Proteomics Research Products
Waters Corp. Offers Proteolabels Software
Gemini Biosciences Introduces New Proteomics and Antibody Services
Waters Introduces a New Data Acquisition Mode, SONAR
Genovis Introduces GingisREX

8. RECENT INDUSTRY ACTIVITY

Proteomics International Partners with Dimerix
SCIEX & NUS Faculty of Science Launches Training Centre for Proteomics and Mass Spectrometry
ARCH Venture Partners & Versant Ventures Establish Vividion Therapeutics
SYGNIS AG Acquires Expedeon Holdings

9. FOCUS ON SELECT KEY PLAYERS

ActivX Biosciences, Inc. (USA)
Agilent Technologies, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
Bruker Daltonics, Inc. (USA)
Caprion Biosciences, Inc. (Canada)
Digilab, Inc. (USA)
GE Healthcare (United Kingdom)
Geneva Bioinformatics S.A. (Switzerland)
Merck KGaA (Germany)
PerkinElmer, Inc. (USA)
Shimadzu Corporation (Japan)
Millipore Sigma (USA)
Thermo Fisher Scientific, Inc. (USA)
Waters Corp. (USA)
Xencor, Inc. (USA)

10. GLOBAL MARKET PERSPECTIVE

Table 10: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 11: World Historic Review for Proteomics by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 12: World 14-Year Perspective for Proteomics by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2011, 2
and 2024 (includes corresponding Graph/Chart)
Table 13: World Recent Past, Current & Future Analysis for Proteomics by Segment – Instruments, Reagents, and Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 14: World Historic Review for Proteomics by Segment – Instruments, Reagents, and Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 15: World 14-Year Perspective for Proteomics by Segment – Percentage Breakdown of Dollar Sales for Instruments, Reagents, and Services Markets for Years 2011, 2017 and 2
(includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A.Market Analysis
Current & Future Analysis
Personalized Medicine – A Major Driver for the Proteomics Market
Companies and Investors Bullish on Personalized Medicine Market in the US
Government Agencies Push for Personalized Medicines
FDA Approvals of Personalized Medicines Continue to Rise
FDA Approved Personalized Medicines: 2016 & 2017
Cancer Presumes Epidemic Proportion in the US
Table 16: New Cancer Cases by Gender and Affected Site in the US (2017E) (includes corresponding Graph/Chart)
Table 17: Cancer Related Deaths by Gender and Affected Site in the US (2016) (includes corresponding Graph/Chart)
Table 18: New Cancer Cases in the US by State (20176) (includes corresponding Graph/Chart)
Proteomics to Provide POCT for Patients in Hospice Care
Demographic Changes Offer Growth Opportunities
Table 19: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Proteomics Sample Preparation Market
Product Launches
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 20: The US Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 21: The US Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2. CANADA

A.Market Analysis
Rising Incidence of Chronic Diseases Spurs Proteomics Demand
Table 22: New Cancer Cases in Canada (2017E): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart)
Table 23: New Cancer Cases in Canada by Province: 2017E (includes corresponding Graph/Chart)
Table 24: New Cancer Cases in Canada by Age Group: 2017E (includes corresponding Graph/Chart)
Table 25: Cancer Related Deaths in Canada (2017E): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart)
Caprion Biosciences Inc. – A Key Player (Canada)
B.Market Analytics
Table 26: Canadian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 27: Canadian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. JAPAN

A.Market Analysis
Demographics Drive Market Growth
Table 28: Japanese Population by Age Group (2017E): Percentage Breakdown for 0-14 Years, 15-24 Years, 25-
Years, 55-64 Years, 64 Years and Above (includes corresponding Graph/Chart)
Shimadzu Corp. – A Key Player
B.Market Analytics
Table 29: Japanese Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 30: Japanese Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. EUROPE

A.Market Analysis
Proteomics Market in Europe
Aging Population to Drive Demand for Proteomics
Table 31: EU-28 Country-wise Statistics of 65+ Population as % of Total Population: 2016 (includes corresponding Graph/Chart)
Cancer Trends
Table 32: Number of New Cancer Cases in Europe (2012-2030) (in Million) (includes corresponding Graph/Chart)
European Personalized Medicine Market to Exhibit Robust Growth
Europe Heading towards Massive Improvements in Personalized Medicine
Personalized Medicine Big on EU Agenda – A Peek into EC Investments in This Space
Proteomics Research in Europe – An Overview
Protein Identification Market
Protein Separation Market
Market Challenges
Gaining Edge in the Proteomics Industry – Player Strategies
Select Key Players
B.Market Analytics
Table 33: European Recent Past, Current & Future Analysis for Proteomics by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2
through 2024 (includes corresponding Graph/Chart)
Table 34: European Historic Review for Proteomics by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 35: European 14-Year Perspective for Proteomics by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

4a. FRANCE
Market Analysis
Table 36: French Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 37: French Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4b. GERMANY
A.Market Analysis
Select Key Player – Merck KGaA (Germany)
B.Market Analytics
Table 38: German Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 39: German Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4c. ITALY
Market Analysis
Table 40: Italian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 41: Italian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM
A.Market Analysis
Highlights
Increased Support for Personalized Medicine to Drive Proteomics Demand
Product Launch
Strategic Corporate Development
GE Healthcare (United Kingdom) – A Key Player
B.Market Analytics
Table 42: The UK Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 43: The UK Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4e. REST OF EUROPE
A.Market Analysis
Spain – Poised to become a Reckoning Force in Personalized Medicines
Product Launches
Key Player
B.Market Analytics
Table 44: Rest of European Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 45: Rest of European Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A.Market Analysis
Healthcare Spending in Asia-Pacific: On the Rise
China
Government Support Drives Personalized Medicine Market in China
India
Indian Scientific Research towards Functional Genomics and Proteomics
Product Launch
Strategic Corporate Development
B.Market Analytics
Table 46: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 47: Asia-Pacific Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

6. LATIN AMERICA

Market Analysis
Table 48: Latin American Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 49: Latin American Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

7. REST OF WORLD

Market Analysis
Table 50: Rest of World Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 51: Rest of World Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 75 (including Divisions/Subsidiaries – 79) The United States (45) Canada (4) Japan (2) Europe (24) – France (2) – Germany (7) – The United Kingdom (7) – Rest of Europe (8) Asia-Pacific (Excluding Japan) (4)



★調査レポート[プロテオミクスの世界市場] (コード:GIA906037)販売に関する免責事項を必ずご確認ください。
★調査レポート[プロテオミクスの世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆